Lineage Cell Therapeutics, Inc.
AMEX:LCTXBiotechnology
Healthcare
$0.84 -2.80%
-$0.04 today
- Market cap
- $212.10M
- Beta
- 1.51
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$0.26
52W Low $0.85High $2.09
Volume 1.22M
Average 1.19M
Price history
Lineage Cell Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-52.63%
Period high
$1.96
Period low
$0.80
Latest
$0.84
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 12, 2026 | Nov 12, 2026 | |
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| 10-Q | Aug 6, 2026 | Aug 6, 2026 | |
| 8-K | Aug 6, 2026 | Aug 6, 2026 | |
| SC 13G | Jul 29, 2026 | Jul 29, 2026 | |
| 4 | Jul 2, 2026 | Jul 2, 2026 | |
| 4 | Jul 2, 2026 | Jul 2, 2026 | |
| 4 | Jul 2, 2026 | Jul 2, 2026 | |
| 4 | Jul 2, 2026 | Jul 2, 2026 | |
| 4 | Jul 2, 2026 | Jul 2, 2026 | |
| 4 | Jul 2, 2026 | Jul 2, 2026 | |
| 8-K | Jun 12, 2026 | Jun 12, 2026 | |
| 8-K | May 12, 2026 | May 12, 2026 | |
| 10-Q | May 12, 2026 | May 12, 2026 | |
| DEFA14A | Apr 29, 2026 | Apr 29, 2026 |
Competitors
Who does Lineage Cell Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about LCTX's filings, answered from its disclosures.
What is the latest LCTX filing?
The latest filing shown is 10-Q dated Nov 12, 2026.
How many recent filings does LCTX have?
Intrinsic Alpha currently shows 20 recent filings for LCTX.
Continue the stock analysis
Jump to another research area for this company.